Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@giconnectInfo Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3359087302.png) @giconnectInfo GI CONNECT

GI CONNECT posts on X about txs the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::3359087302/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3359087302/c:line/m:interactions.svg)

- X Week XXXXXXX +5.40%
- X Month XXXXXXXXX -XX%
- X Months XXXXXXXXX +108%
- X Year XXXXXXXXX +85%

### Mentions: X [#](/creator/twitter::3359087302/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3359087302/c:line/m:posts_active.svg)

- X Week X +33%
- X Month X -XX%
- X Months XX +67%
- X Year XX +39%

### Followers: XXXXX [#](/creator/twitter::3359087302/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3359087302/c:line/m:followers.svg)

- X Week XXXXX +0.32%
- X Month XXXXX +0.41%
- X Months XXXXX +8.60%
- X Year XXXXX +9.30%

### CreatorRank: XXXXXXX [#](/creator/twitter::3359087302/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3359087302/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::3359087302/influence)
---

**Social category influence**
[countries](/list/countries)  XXXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[txs](/topic/txs) #2

**Top accounts mentioned or mentioned by**
[@diceeurope](/creator/undefined) [@waroncancer](/creator/undefined) [@andreasart](/creator/undefined) [@pancan](/creator/undefined) [@natpancfdn](/creator/undefined) [@efratdotan](/creator/undefined) [@drshubhampant](/creator/undefined) [@helops79](/creator/undefined) [@profkherrmann](/creator/undefined) [@oncbrothers](/creator/undefined) [@nanets1](/creator/undefined) [@gicancer](/creator/undefined) [@ncukcharity](/creator/undefined) [@lizzysmyth1](/creator/undefined) [@asco](/creator/undefined) [@letswinpc](/creator/undefined)
### Top Social Posts [#](/creator/twitter::3359087302/posts)
---
Top posts by engagements in the last XX hours

"Systemic chemotherapy is standard Tx for metastatic PDAC but molecularly targeted Txs & IO may have a role for specific pts Explore this topic in an animated video from Prof. Eileen OReilly Chemotherapy strategies for MPDAC Watch the video in this post 📺 Endorsed by @WarOnCancer @PanCAN @dice_europe @NatPancFdn Supported by an Independent Educational Grant from Ipsen USA"  
[X Link](https://x.com/giconnectInfo/status/1968663448205627453) [@giconnectInfo](/creator/x/giconnectInfo) 2025-09-18T13:08Z 2190 followers, 648.2K engagements


"Systemic chemotherapy is standard Tx for metastatic PDAC but molecularly targeted Txs & IO may have a role for specific pts Explore 2nd line treatment options in an animated video from Prof. @efratdotan Chemotherapy strategies for mPDAC Watch the video in this post 📺 Endorsed by @WarOnCancer @PanCAN @dice_europe @NatPancFdn Supported by an Independent Educational Grant from Ipsen USA"  
[X Link](https://x.com/giconnectInfo/status/1968666637319413823) [@giconnectInfo](/creator/x/giconnectInfo) 2025-09-18T13:21Z 2190 followers, 666.9K engagements


"👴 Patient case: 61y male with #CRC progression following chemotherapy + monoclonal antibody treatment Which treatment decisions would you make for him 2nd 3rd line + beyond Test your knowledge in this patient case video from Prof. @andrea_sart 📺 Later- line treatment strategies in metastatic colorectal cancer: rechallenge vs switching 🤝 Endorsed by @WarOnCancer @dice_europe Supported by an Independent Educational Grant from Bayer #colorectalcancer #MedEd #OncTwitter #CRCSM"  
[X Link](https://x.com/giconnectInfo/status/1978817706054037750) [@giconnectInfo](/creator/x/giconnectInfo) 2025-10-16T13:38Z 2190 followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@giconnectInfo Avatar @giconnectInfo GI CONNECT

GI CONNECT posts on X about txs the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

  • X Week XXXXXXX +5.40%
  • X Month XXXXXXXXX -XX%
  • X Months XXXXXXXXX +108%
  • X Year XXXXXXXXX +85%

Mentions: X #

Mentions Line Chart

  • X Week X +33%
  • X Month X -XX%
  • X Months XX +67%
  • X Year XX +39%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.32%
  • X Month XXXXX +0.41%
  • X Months XXXXX +8.60%
  • X Year XXXXX +9.30%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence countries XXXXX% currencies XXXX%

Social topic influence txs #2

Top accounts mentioned or mentioned by @diceeurope @waroncancer @andreasart @pancan @natpancfdn @efratdotan @drshubhampant @helops79 @profkherrmann @oncbrothers @nanets1 @gicancer @ncukcharity @lizzysmyth1 @asco @letswinpc

Top Social Posts #


Top posts by engagements in the last XX hours

"Systemic chemotherapy is standard Tx for metastatic PDAC but molecularly targeted Txs & IO may have a role for specific pts Explore this topic in an animated video from Prof. Eileen OReilly Chemotherapy strategies for MPDAC Watch the video in this post 📺 Endorsed by @WarOnCancer @PanCAN @dice_europe @NatPancFdn Supported by an Independent Educational Grant from Ipsen USA"
X Link @giconnectInfo 2025-09-18T13:08Z 2190 followers, 648.2K engagements

"Systemic chemotherapy is standard Tx for metastatic PDAC but molecularly targeted Txs & IO may have a role for specific pts Explore 2nd line treatment options in an animated video from Prof. @efratdotan Chemotherapy strategies for mPDAC Watch the video in this post 📺 Endorsed by @WarOnCancer @PanCAN @dice_europe @NatPancFdn Supported by an Independent Educational Grant from Ipsen USA"
X Link @giconnectInfo 2025-09-18T13:21Z 2190 followers, 666.9K engagements

"👴 Patient case: 61y male with #CRC progression following chemotherapy + monoclonal antibody treatment Which treatment decisions would you make for him 2nd 3rd line + beyond Test your knowledge in this patient case video from Prof. @andrea_sart 📺 Later- line treatment strategies in metastatic colorectal cancer: rechallenge vs switching 🤝 Endorsed by @WarOnCancer @dice_europe Supported by an Independent Educational Grant from Bayer #colorectalcancer #MedEd #OncTwitter #CRCSM"
X Link @giconnectInfo 2025-10-16T13:38Z 2190 followers, XX engagements

@giconnectInfo
/creator/twitter::giconnectInfo